TMDX Q1 2020 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$4B

Q1 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$8M+61.0% YoY

Gross Profit

$5M64.5% margin

Operating Income

-$8M-106.5% margin

Net Income

-$9M-117.6% margin

EPS (Diluted)

$-0.42

QoQ Revenue Growth

+24.3%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$385,000

Balance Sheet

Total Assets

$97M

Total Liabilities

$50M

Stockholders' Equity

$47M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$5M	+61.0%
Gross Profit	$5M	$3M	+88.9%
Operating Income	-$8M	-$6M	-34.5%
Net Income	-$9M	-$7M	-28.4%

Revenue Segments

OCS Heart Product

$4M55%

OCS Lung Product

$2M27%

OCS Liver Product

$1M18%

Geographic Segments

UNITED STATES

$5M81%

Non US And UK

$1M19%